期刊文献+

重组泛素连接酶SH2-U—box/RING的构建与表达 被引量:1

Construction and Expression of Recombinant Ubiquitin ligase SH2-U- box/RING
原文传递
导出
摘要 目的构建重组泛素连接酶SH2-U—box、SH2-RING,并克隆进入pFlag—CMV4真核表达载体,为研究靶向降解慢性粒细胞白血病(chronic myelocytic leukemia,CML)患者瘤细胞中过度活化的BCR/ABL,抑制肿瘤细胞的生长提供基础。方法设计引物,扩增接头分子Grb2的SH2结构域以及E3泛素连接酶CHIP的U—box、Cb1的RING结构域,通过重组PCR,将SH2分别与U—box、RING进行融合,融合片段双酶切之后插入真核表达载体pFlag—CMV4,经过酶切鉴定及测序后,转染HEK293T细胞,Western印迹验证重组质粒的表达。结果PCR结果提示SH2-U—box条带大小888bp,SH2一RING大小为633bp,重组质粒酶切鉴定和测序结果均正确,转染后可见融合蛋白的表达。结论成功构建真核重组表达载体pFlag—CMV4-SH2-U—box和pFlag—CMV4-SH2-RING,转染HEK293T细胞后能够正确表达,为后续研究奠定了基础。 Objective To construct recombinant ubiquitin ligases SH2-U-box and SH2-RING into a eukaryotic expression vector pFLAG-CMV4, for further study of targeted degradation of BCR/ ABL excessively expressed in CML cells of and subsequent inhibition of the tumor cells. Methods SH2 domain of Grb2, U-box domain of CHIP and RING domain of Cbl were amplified with designed primers by routine PCR respectively. The SH2 domain fragment was then fused with U-box or RING domain fragment by recombinant PCR. The recombinant fragments were digested using double restric- tion enzymes EcoR I/EcoR V and inserted into the eukaryotic expression vector pFLAG-CMV4, and identified by enzyme digestion and sequencing. The constructed recombination plasmid was transfect- ed into HEK293T cells to verify the expression by Western-blot. Results PCR results showed the SH2-U-box and SH2-RING bands at size of 888bp and 633bp respectively. The constructed recombi- nation plasmids were verified by enzyme digestion and DNA sequencing. The fusion proteins were ex- pressed in HEK293T cell after transfection. Conclusion The eukaryotic expression vectors pFLAG- CMV4-SH2-U-box and pFLAG-CMV4-SH2-RING were successfully constructed, and confirmed to express correctly in HEK293T cell.
出处 《医学分子生物学杂志》 CAS CSCD 2012年第1期6-10,共5页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30800492,30873003,30972723)
关键词 泛素 慢性粒细胞白血病 重组质粒 ubiquitin chronic myelocytic leukemia recombinant E3 ubiquitin ligase
  • 相关文献

参考文献13

  • 1StIERBEN()U D , , DRUKER B J. AI)plying lhe dist.ocry of thePhiladelphia ehromosome i J 1. ,I Clin Invest. 2007.117 ( 8 ) :2067- 2074.
  • 2uGOGA A ,mclauchlin j ,afar d e ,et alAlternative signals to RAS for bemmatopoietic transformation by the BCR-ABL oncogene [J]. Celll,1995,82(6):981-988.
  • 3HEN S Y. BOLTON E. MOHI M G. el aL Phosphalidyli,,osil,d 3-ki- ,,ase p85 I alpha i ,ubtmit-depeudem interac'ti,)n ilh 13('R/ABI.- rt'lated fushm t,,rosint, kinase.:moleular mhanims and biologi- 'al consequ'nesi J i. Mol Cell Boil ,2005,25 (18) :8001-8008.
  • 4HEANEY C, KOLIBABA K,BHAT A ,te al Direcl binding of CRKL to bcr-abl is not required for BCR-ABL transfomation [J].Blood ,1997,89(1):297-306.
  • 5REN R. Mechanisms of BCR-ABI in the pathogcncsis f (.hronit' myel.g,nous leukaemia[ J ]. Nat Re'.. Can,.cr, 2005,5 ( 3 ) : 172- 183.
  • 6GI,ICKMAN M It, CIECtt>,NOVER A,Theuhiquitin-proteasome proteolytic lmth'c,ay: destruction tbr tilt' sake' of construt'lion [J].Ph?siol Re' ,2002,82 ( 2 ) :373-428.
  • 7BURGER A M,SETH A K. The ubiquitin-mediated protein degra- dation pathway in cancer:therapeutic implications[ J ]. Eur J Canc- er ,2004,40( 15 ) :2217-2229.
  • 8SAKAMOTO K M. Ubiquitin-dependent proteolysis:its role in hu- man diseases and the design of therapeutic strategies[ J 1. Mol Gen- et Metab ,2002,77(1-2) :44-56.
  • 9SCHIFFER C A. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia [ J ]. N Engl J Med, 2007,357 ( 3 ) : 258- 265.
  • 10SHAH N P, KASAP C, WEIER C, et al. Transient potent BCR- ABL inhibition is suficient to commit chronicmyeloid leukemia cells irreversibly to apoptosis [ J ]. Cancer Cell, 2008,14 ( 6 ) : 485- 493.

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部